116 related articles for article (PubMed ID: 38165714)
41. Effective Distribution of Gold Nanorods in Ordered Thick Mesoporous Silica: A Choice of Noninvasive Theranostics.
Prasad R; Selvaraj K
ACS Appl Mater Interfaces; 2023 Oct; 15(40):47615-47627. PubMed ID: 37782885
[TBL] [Abstract][Full Text] [Related]
42. Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer.
Martínez-Carmona M; Ho QP; Morand J; García A; Ortega E; Erthal LCS; Ruiz-Hernandez E; Santana MD; Ruiz J; Vallet-Regí M; Gun'ko YK
Inorg Chem; 2020 Jul; 59(14):10275-10284. PubMed ID: 32628466
[TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory and antioxidant effects of nanoformulations composed of metal-organic frameworks delivering rutin and/or piperine natural agents.
AbouAitah K; Higazy IM; Swiderska-Sroda A; Abdelhameed RM; Gierlotka S; Mohamed TA; Szałaj U; Lojkowski W
Drug Deliv; 2021 Dec; 28(1):1478-1495. PubMed ID: 34254539
[TBL] [Abstract][Full Text] [Related]
44. Pectin coated nanostructured lipid carriers for targeted piperine delivery to hepatocellular carcinoma.
Shehata EMM; Gowayed MA; El-Ganainy SO; Sheta E; Elnaggar YSR; Abdallah OY
Int J Pharm; 2022 May; 619():121712. PubMed ID: 35367582
[TBL] [Abstract][Full Text] [Related]
45. Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.
Wang N; Ali A; Liu Z; Chi H; Lv Z; Zhao X; Zhang Z; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2023 Oct; 258():115536. PubMed ID: 37295260
[TBL] [Abstract][Full Text] [Related]
46. Co-Delivery System of Curcumin and Colchicine Using Functionalized Mesoporous Silica Nanoparticles Promotes Anticancer and Apoptosis Effects.
AbouAitah K; Soliman AAF; Swiderska-Sroda A; Nassrallah A; Smalc-Koziorowska J; Gierlotka S; Lojkowski W
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559264
[TBL] [Abstract][Full Text] [Related]
47. Gd-Al co-doped mesoporous silica nanoparticles loaded with Ru(bpy)₃²⁺ as a dual-modality probe for fluorescence and magnetic resonance imaging.
Zhang D; Gao A; Xu Y; Yin XB; He XW; Zhang YK
Analyst; 2014 Sep; 139(18):4613-9. PubMed ID: 25046328
[TBL] [Abstract][Full Text] [Related]
48. Antibacterial and anticancer activities of asymmetric lollipop-like mesoporous silica nanoparticles loaded with curcumin and gentamicin sulfate.
Cheng Y; Zhang Y; Deng W; Hu J
Colloids Surf B Biointerfaces; 2020 Feb; 186():110744. PubMed ID: 31874345
[TBL] [Abstract][Full Text] [Related]
49. Delivery of [Ru(η
Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
[TBL] [Abstract][Full Text] [Related]
50. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
Cong VT; Gaus K; Tilley RD; Gooding JJ
Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
[TBL] [Abstract][Full Text] [Related]
51. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
52. Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.
Alves Rico SR; Abbasi AZ; Ribeiro G; Ahmed T; Wu XY; de Oliveira Silva D
Nanoscale; 2017 Aug; 9(30):10701-10714. PubMed ID: 28678269
[TBL] [Abstract][Full Text] [Related]
53. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].
Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J
Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746
[TBL] [Abstract][Full Text] [Related]
54. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
55. Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer.
Moin A; Wani SUD; Osmani RA; Abu Lila AS; Khafagy ES; Arab HH; Gangadharappa HV; Allam AN
Drug Deliv; 2021 Dec; 28(1):1626-1636. PubMed ID: 34328806
[TBL] [Abstract][Full Text] [Related]
56. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy.
Wang J; Wang Y; Liu Q; Yang L; Zhu R; Yu C; Wang S
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26511-26523. PubMed ID: 27619078
[TBL] [Abstract][Full Text] [Related]
57. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect.
Senthilkumar R; Karaman DŞ; Paul P; Björk EM; Odén M; Eriksson JE; Rosenholm JM
Biomater Sci; 2015 Jan; 3(1):103-11. PubMed ID: 26214194
[TBL] [Abstract][Full Text] [Related]
58. Metallointercalator [Ru(dppz)
Yusoh NA; Leong SW; Chia SL; Harun SN; Rahman MBA; Vallis KA; Gill MR; Ahmad H
ACS Chem Biol; 2020 Feb; 15(2):378-387. PubMed ID: 31898884
[TBL] [Abstract][Full Text] [Related]
59. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
60. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
